Gastroenterology
Volume 138, Issue 7 , Pages 2332-2340, June 2010

Persistence of Cognitive Impairment After Resolution of Overt Hepatic Encephalopathy

  • Jasmohan S. Bajaj

      Affiliations

    • Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, Virginia
    • Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, Wisconsin
    • Corresponding Author InformationReprint requests Address requests for reprints to: Jasmohan S. Bajaj, MD, MS, Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and McGuire VA Medical Center, 1201 Broad Rock Boulevard, Richmond, Virginia 23249. fax: (804) 675 5816
  • ,
  • Christine M. Schubert

      Affiliations

    • Division of Biostatistics, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, Virginia
  • ,
  • Douglas M. Heuman

      Affiliations

    • Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, Virginia
  • ,
  • James B. Wade

      Affiliations

    • Division of Psychology, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, Virginia
  • ,
  • Douglas P. Gibson

      Affiliations

    • Division of Psychology, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, Virginia
  • ,
  • Allyne Topaz

      Affiliations

    • Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, Virginia
  • ,
  • Kia Saeian

      Affiliations

    • Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, Wisconsin
  • ,
  • Muhammad Hafeezullah

      Affiliations

    • Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, Wisconsin
  • ,
  • Debulon E. Bell

      Affiliations

    • Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, Virginia
  • ,
  • Richard K. Sterling

      Affiliations

    • Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, Virginia
  • ,
  • R. Todd Stravitz

      Affiliations

    • Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, Virginia
  • ,
  • Velimir Luketic

      Affiliations

    • Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, Virginia
  • ,
  • Melanie B. White

      Affiliations

    • Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, Virginia
  • ,
  • Arun J. Sanyal

      Affiliations

    • Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, Virginia

Received 22 December 2009; accepted 11 February 2010. published online 22 February 2010.

Background & Aims

In patients with cirrhosis, hepatic encephalopathy (HE) has acute but reversible as well as chronic components. We investigated the extent of residual cognitive impairment following clinical resolution of overt HE (OHE).

Methods

Cognitive function of cirrhotic patients was evaluated using psychometric tests (digit symbol, block design, and number connection [NCT-A and B]) and the inhibitory control test (ICT). Improvement (reduction) in ICT lures and first minus second halves (ΔL1–2) were used to determine learning of response inhibition. Two cross-sectional studies (A and B) compared data from stable cirrhotic patients with or without prior OHE. We then prospectively assessed cognitive performance, before and after the first episode of OHE.

Results

In study A (226 cirrhotic patients), 54 had experienced OHE, 120 had minimal HE, and 52 with no minimal HE. Despite normal mental status on lactulose after OHE, cirrhotic patients were cognitively impaired, based on results from all tests. Learning of response inhibition (ΔL1–2 ≥1) was evident in patients with minimal HE and no minimal HE but was lost after OHE. In study B (50 additional patients who developed ≥1 documented OHE episode during follow-up), the number of OHE hospitalizations correlated with severity of residual impairment, indicated by ICT lures (r = 0.5, P = .0001), digit symbol test (r = −0.39, P = .002), and number connection test-B (r = 0.33, P = .04). In the prospective study (59 cirrhotic patients without OHE), 15 developed OHE; ICT lure response worsened significantly after OHE (12 before vs 18 after, P = .0003), and learning of response inhibition was lost. The 44 patients who did not experience OHE did not have deteriorations in cognitive function in serial testing.

Conclusions

In cirrhosis, episodes of OHE are associated with persistent and cumulative deficits in working memory, response inhibition, and learning.

Keywords: Cirrhosis, Portal Hypertension, Cognition, Complications

Abbreviations used in this paper: ICT, inhibitory control test, ΔL1–2, lures on the first half of ICT minus those in the second half, HE, hepatic encephalopathy, MELD, Model for End-Stage Liver Disease, SONIC, spectrum of neurocognitive impairment in cirrhosis, TIPS, transjugular intrahepatic portosystemic shunting

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Conflicts of interest The authors disclose the following: Dr Bajaj is a consultant for and receives independent grant support from Salix and Ocera. Dr Sanyal is a consultant for Salix Pharmaceuticals. The remaining authors disclose no conflicts.

 Funding Supported in part by the American College of Gastroenterology Junior Faculty Development Award, and by clinical research center grants MO1-RR00065 and MO1-RR00058, NCRR, and NIH (awarded to J.S.B.).

PII: S0016-5085(10)00206-4

doi:10.1053/j.gastro.2010.02.015

Gastroenterology
Volume 138, Issue 7 , Pages 2332-2340, June 2010